Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peat

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3Terrence L Smalley, Andrew J Peat, Joyce A Boucheron, et al.
Viruses|October 17, 2015
Multi-Modal Imaging with a Toolbox of Influenza A Reporter VirusesVy Tran, Daniel S Poole, Justin J Jeffery, et al.
Plos One|April 21, 2015
Increasing Accuracy: A New Design and Algorithm for Automatically Measuring Weights, Travel Direction and Radio Frequency Identification (RFID) of PenguinsVsevolod Afanasyev, Sergey V Buldyrev, Michael J Dunn, et al.
Open Forum Infectious Diseases|May 2, 2019
Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With InfluenzaAnuradha Madan, Shuguang Chen, Phillip Yates, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptorStephen C McKeown, David F Corbett, Aaron S Goetz, et al.
ACS Pharmacology & Translational Science|February 19, 2026
SCaN: A Screening and Characterization Platform for Nanosuspensions Enables In Vivo Delivery of a Crystalline hRpn13<sup>Pru</sup> DegraderChristine S Brugger-Muli, Snehal M Gaikwad, Wendy du Bois, et al.
Molecular Cancer Therapeutics|September 18, 2020
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal MelanomaBih-Rong Wei, Shelley B Hoover, Cody J Peer, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Synthesis and activity of small molecule GPR40 agonistsDulce M Garrido, David F Corbett, Kate A Dwornik, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Synthesis and evaluation of 7-substituted-3-cyclobutylamino-4H-1,2,4-benzothiadiazine-1,1-dioxide derivatives as K(ATP) channel agonistsAndrew J Peat, Claire Townsend, Jennings F Worley, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3Terrence L Smalley, Andrew J Peat, Joyce A Boucheron, et al.
Viruses|October 17, 2015
Multi-Modal Imaging with a Toolbox of Influenza A Reporter VirusesVy Tran, Daniel S Poole, Justin J Jeffery, et al.
Plos One|April 21, 2015
Increasing Accuracy: A New Design and Algorithm for Automatically Measuring Weights, Travel Direction and Radio Frequency Identification (RFID) of PenguinsVsevolod Afanasyev, Sergey V Buldyrev, Michael J Dunn, et al.
Open Forum Infectious Diseases|May 2, 2019
Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With InfluenzaAnuradha Madan, Shuguang Chen, Phillip Yates, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptorStephen C McKeown, David F Corbett, Aaron S Goetz, et al.
ACS Pharmacology & Translational Science|February 19, 2026
SCaN: A Screening and Characterization Platform for Nanosuspensions Enables In Vivo Delivery of a Crystalline hRpn13<sup>Pru</sup> DegraderChristine S Brugger-Muli, Snehal M Gaikwad, Wendy du Bois, et al.
Molecular Cancer Therapeutics|September 18, 2020
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal MelanomaBih-Rong Wei, Shelley B Hoover, Cody J Peer, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Synthesis and activity of small molecule GPR40 agonistsDulce M Garrido, David F Corbett, Kate A Dwornik, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Synthesis and evaluation of 7-substituted-3-cyclobutylamino-4H-1,2,4-benzothiadiazine-1,1-dioxide derivatives as K(ATP) channel agonistsAndrew J Peat, Claire Townsend, Jennings F Worley, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.
Pageof 8